Zeiss重申中国是一个关键的创新中心, 投资42亿元, 并推出新近视管理透镜。 Zeiss reaffirms China as a key innovation hub with a 4.2 billion yuan investment and launches new myopia management lenses.

Zeiss Vision是一家德国光学公司,它重申中国是一个重要的全球创新枢纽和主要市场,凸显了中国对六个广州实体的42亿元投资,以及世界经济论坛承认的“灯塔工厂”使用AI和数字双胞胎来推动个性化,将交货时间缩短29%。 Zeiss Vision, a German optics company, reaffirmed China as a key global innovation hub and major market, highlighting its 4.2 billion yuan investment across six Guangzhou entities and a World Economic Forum-recognized "lighthouse factory" using AI and digital twins to boost personalization and cut delivery times by 29%. 在上海光学博览会上,Zeiss揭开了它新的Zeiss MyoAving Lens, 这是一种有临床证据和M.O.V.E.支持的近视管理产品。 At the Shanghai Optics Fair, Zeiss unveiled its new Zeiss MyoActive Lens, a myopia management product backed by clinical evidence and M.O.V.E. 技术。 technology. 该公司正与中山眼科中心和Tentcent Health等机构合作,发展成矫形学、AR/VR和智能眼镜,并报告中国的两位数持续增长。 The company is expanding into orthokeratology, AR/VR, and smart glasses, partnering with institutions like Zhongshan Ophthalmic Center and Tencent Health, and reports sustained double-digit growth in China.